MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells
- 1 May 2009
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 315 (8), 1439-1447
- https://doi.org/10.1016/j.yexcr.2008.12.010
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
This publication has 40 references indexed in Scilit:
- The role of cyclooxygenase-2 and prostaglandins in colon cancerProstaglandins & Other Lipid Mediators, 2007
- RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumour cellsBritish Journal of Cancer, 2006
- Transcriptional Control of COX-2 via C/EBPβArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Re: Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition StagingJNCI Journal of the National Cancer Institute, 2005
- Cyclooxygenase-2 Expression as a New Marker for Patients with Colorectal CancerDiseases of the Colon & Rectum, 2002
- Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and ApoptosisExperimental Cell Research, 1996
- Transcriptional Roles of Nuclear Factor κB and Nuclear Factor-Interleukin-6 in the Tumor Necrosis Factor α-Dependent Induction of Cyclooxygenase-2 in MC3T3-E1 CellsJournal of Biological Chemistry, 1995
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology, 1994
- Aspirin Use and Reduced Risk of Fatal Colon CancerNew England Journal of Medicine, 1991